Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells

Chen Yan , Hu Dong

Current Medical Science ›› 2004, Vol. 24 ›› Issue (11) : 41 -44.

PDF
Current Medical Science ›› 2004, Vol. 24 ›› Issue (11) : 41 -44. DOI: 10.1007/BF02830702
Article

Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells

Author information +
History +
PDF

Abstract

The effects of monoterpene perilly alcohol (POH) alone or in combination with STI571 on the proliferation and apoptosis of the cell line K562 positive for Ber/Abl were investigated. By using cell culture, the effect of the drugs on the proliferation of the cells was studied. TUNEL and flow cytometry assay of FITC-Annexin V and PI labeled cells were applied to detect the effects of the drugs on the apoptosis of the cells. The results showed that at 36 h, IC50 of POH on K562 positive for Bcr/Abl and HL-60 negative for Bcr/Abl were 81.0±11.3 μmol/L and 113.6±23.4 μmol/L respectively (P>0.05). POH could inhibit the proliferation of K562 in a time- and dose-dependent manner with the inhibitory rate of 100 μmol/L POH on K562 cells at 36 h being (53.2±3.65)%. K562 cells were more sensitive to STI571 than POH. IC50 of STI571 on K562 cells in 36 h was (0.256±0.054) μmol/L. In a time- and dose-dependent manner, POH induced the apoptosis of K562 cells with the percentage of apoptotic cells by 100 μmol/L POH at 40 h being (21.0±3.3) %. Both 100 μmol/L POH and 0.2 μmol/L STI571 had the same inhibitory effects on the K562 cells at 36 h. But at 12 and 24 h, the inhibitory rate of POH was significantly higher than that of STI571 (P<0.05) and the ability of STI571 inducing apoptosis at 36 h was greater than that of POH. 50 μmol/L, 100 μmol/L and 200 μmol/L POH in combination with 0.2 μmol/L STI571 could obviously increase the inhibitory effects on the cellular proliferation. Combined use of 50 μmol/L, 100 μmol/L, 200 μmol/L with 0.2 μmol/L STI571 could strongly induced apoptosis, especially 200 μmol/L POH in combination with 0.2 μmol/L STI571. It was concluded that the antileukemia effect of POH had no obvious Bcr/Abl positive selectivity. POH can inhibit the proliferation of K562 and induce the apoptosis in a time- and dose-dependent manner. K562 cells were more sensitive to STI571 than POH. POH in combination with STI571 could obviously enhance the abilities of STI571 inhibiting the proliferation and inducing apoptosis of K562 cells.

Keywords

perillyl alcohol / STI571 / K562 / proliferation / apoptosis

Cite this article

Download citation ▾
Chen Yan, Hu Dong. Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells. Current Medical Science, 2004, 24(11): 41-44 DOI:10.1007/BF02830702

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

DeiningerM W, GoldmanJ M, MeloJ V. The molecular biology of chronic myeloid leukemia. Blood, 2000, 96: 3343-3343

[2]

CrowellP L.. Prevention and therapy of cancer by dietary monoterpenes. J. Nutr, 1999, 129(3): 775S

[3]

BelangerJ T. Perillyl alcohol: applications in oncology. Altern Med Rev, 1998, 3(6): 448-448

[4]

HuD, ChenY. Anticancer effect of the food derived perillyl alcohol. Clin Hematol J (Chinese), 2001, 14(3): 141-141

[5]

SahinM B, PermanS M, JenkinsG, et al.. Perillyl alcohol selectively induces G0/G1 arrest and apoptosis in Bcr/Abl-transformed myeloid cell lines. Lukemia, 1999, 13(10): 1581-1581

[6]

HeL, MoH, HadisusiloS, et al.. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr, 1997, 127(5): 668-668

[7]

AriaziE A, SatomiY, EllisM J, et al.. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol. Cancer Res, 1999, 59(8): 1917-1917

[8]

ClarkS S, PermanS M, SahinM B, et al.. Antileukemia activity of perillyl alcohol (POH): uncoupling apoptosis from G0/G1 arrest suggests that the primary effect of POH on Bcr/Abl-transformed cells is to induce growth arrest. Leukemia, 2002, 16(2): 213-213

[9]

ThiesingJ T, Ohno-JonesS, KolibabaK S, et al.. Efficacy of STI571, an abl tyrosine kinase inhibitor, in conjunction with other antileukemic agents against bcr-ablpositive cells. Blood, 2000, 96(9): 3195-3195

[10]

SunX, LaytonJ E, ElefantyA, et al.. Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL-expressing cells, demonstrating synergy between AG490 and STI571. Blood, 2001, 97: 2008-2008

AI Summary AI Mindmap
PDF

87

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/